newsfilter
← Latest News
Business Wire·

AIM ImmunoTech Provides Update on Jorgl Activist Group Litigation

AIM ImmunoTech Inc. (NYSE:AMERICAN) ("AIM" or the "Company"), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, today issued the following statement